• / Free eNewsletters & Magazine
  • / My Account
Home>Authors>Damien Conover

Damien Conover

  1. All
  2. Morningstar Articles
  3. Videos
  4. Investing
  5. Research
  1. J&J's Strong 2Q Led by Pharmaceuticals

    Unexpectedly robust sales of hepatitis C drug Olysio helped lift the drug giant’s pharma segment, while medical devices struggled, says Morningstar’s Damien Conover .

  2. Health Care a Leader in Moat Stocks

    The health-care sector has a higher volume of moat firms compared with other industries, and companies' patent and brand power deliver very strong returns on capital.

  3. The Friday Five

    This week: Financial-services firms post lukewarm earnings, two tech giants strike a deal, Time Warner turns down a foxy offer, and more.

  4. Prescribe to Pharma for Emerging-Markets Growth

    Many developed-country health-care firms have deep roots in emerging markets and can be a good way to gain exposure, says Morningstar's Damien Conover .

  5. Johnson & Johnson's Pharma Group Leading the Way

    The firm's consumer and medical-device group are lagging, but strong results from the pharmaceuticals side should drive earnings throughout this year and into 2015, says Morningstar's Damien Conover .

  6. Pfizer-Astra Deal Will Get Done

    Cost-cutting, tax opportunities, and oncology synergies are motivating factors for Pfizer, and the firms will likely agree to merge, says Morningstar's Damien Conover .

  7. The Friday Five

    Bank of America makes a boo-boo, Twitter shares are still flying too high, Morningstar heads to Omaha, and more.

  8. The Friday Five

    Draghi drops a hint, Whole Foods takes a hit, and Alibaba's impending IPO raises questions for Yahoo.

  9. The Sector Is Fairly Valued, but These Stocks Are Not

    A handful of health-care names are selling at premiums now, but buying opportunities are surfacing, as well.

  10. Is the Affordable Care Act Healing Health Care’s Woes?

    As the ultimate impact of Obamacare comes into focus, the sector’s winners and losers are becoming more apparent.

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.